GAROSI, GUIDO
 Distribuzione geografica
Continente #
EU - Europa 3.504
NA - Nord America 3.130
AS - Asia 1.912
SA - Sud America 332
AF - Africa 61
OC - Oceania 10
Totale 8.949
Nazione #
US - Stati Uniti d'America 3.073
RU - Federazione Russa 923
IT - Italia 697
CN - Cina 677
SG - Singapore 622
IE - Irlanda 542
GB - Regno Unito 512
BR - Brasile 290
SE - Svezia 199
KR - Corea 176
HK - Hong Kong 173
DE - Germania 167
FR - Francia 137
UA - Ucraina 104
VN - Vietnam 78
FI - Finlandia 77
IN - India 71
ES - Italia 32
CA - Canada 26
BD - Bangladesh 25
RO - Romania 23
TR - Turchia 20
MA - Marocco 18
MX - Messico 18
NL - Olanda 18
PL - Polonia 18
ZA - Sudafrica 15
CI - Costa d'Avorio 14
JP - Giappone 13
AR - Argentina 12
AT - Austria 11
BE - Belgio 10
AU - Australia 9
IQ - Iraq 9
SI - Slovenia 7
CO - Colombia 6
EC - Ecuador 6
IR - Iran 6
VE - Venezuela 5
CH - Svizzera 4
CR - Costa Rica 4
JM - Giamaica 4
KE - Kenya 4
PK - Pakistan 4
SA - Arabia Saudita 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CL - Cile 3
ID - Indonesia 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PE - Perù 3
TN - Tunisia 3
UZ - Uzbekistan 3
CZ - Repubblica Ceca 2
GE - Georgia 2
HR - Croazia 2
JO - Giordania 2
LT - Lituania 2
MY - Malesia 2
NO - Norvegia 2
PY - Paraguay 2
RS - Serbia 2
SN - Senegal 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GM - Gambi 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IM - Isola di Man 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
NR - Nauru 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 8.949
Città #
Dublin 539
Dallas 473
Southend 418
Singapore 353
Chandler 294
Moscow 259
Ashburn 245
Santa Clara 232
Hefei 209
Fairfield 196
Seoul 175
Siena 171
Hong Kong 169
Beijing 163
Woodbridge 98
Ann Arbor 89
Jacksonville 85
Seattle 84
Cambridge 76
Houston 69
Wilmington 68
Los Angeles 62
Menlo Park 58
Milan 55
New York 53
Florence 52
Boardman 44
Princeton 39
Bengaluru 38
Munich 37
Helsinki 35
Nanjing 35
The Dalles 31
Rome 24
São Paulo 24
Buffalo 23
Ho Chi Minh City 23
Redondo Beach 22
Dearborn 21
Turku 20
Shanghai 19
San Diego 18
San Mateo 18
Messina 17
Stockholm 16
Washington 16
Abidjan 14
Iesi 14
Izmir 14
Warsaw 14
Brooklyn 13
Málaga 13
Nuremberg 13
Chicago 12
Hanoi 12
London 12
Montreal 12
Tianjin 12
Amsterdam 11
Johannesburg 11
Lauterbourg 11
Rio de Janeiro 11
Tokyo 11
Denver 10
Frankfurt am Main 10
Orem 10
Casalecchio di Reno 9
Chennai 9
Marrakesh 9
Poplar 9
Prato 9
Bologna 8
Brussels 8
Casablanca 8
Columbus 8
Council Bluffs 8
Lappeenranta 8
Dong Ket 7
Ljubljana 7
Saronno 7
Toronto 7
Boston 6
Brasília 6
Changsha 6
Codogno 6
Curitiba 6
Mexico City 6
Nanchang 6
Norwalk 6
Paris 6
Phoenix 6
Redwood City 6
San Francisco 6
Shenyang 6
Southwark 6
Belo Horizonte 5
Brescia 5
Guangzhou 5
Hebei 5
Madrid 5
Totale 5.735
Nome #
null 398
ANDAMENTO LONGITUDINALE DI BIOMARKERS DI INFIAMMAZIONE ED IMMUNOATTIVAZIONE IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI RENE: UN RUOLO DELLA REPLICAZIONE DI CMV? 330
Alport syndrome: impact of digenic inheritance in patients management 281
HCMV infection in renal transplant recipients: a retrospective cohort study 261
Clinical and MRI improvement in a case of progressive multifocal leukoencephalopathy 259
Advances in Alport syndrome diagnosis using next-generation sequencing 245
Everolimus in kidney transplant recipients at high cardiovascular risk: a narrative review 245
Epidemiologic study of neonatal jaundice. A survey of contributing factors 224
Diagnostic accuracy of anti-phospholipase A2 receptor (PLA2R) antibodies in idiopathic membranous nephropathy: an Italian experience 222
Expert consensus guidelines for the genetic diagnosis of Alport syndrome 202
Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies 201
SARS-CoV-2 in pleural fluid in a kidney transplant patient 189
Deep Learning Approaches for the Segmentation of Glomeruli in Kidney Histopathological Images 187
null 182
Detection of cryptic mosaicism in X-linked alport syndrome prompts to re-evaluate living-donor kidney transplantation 178
Studies for the evaluation of oxygenation and ozonation of blood during extracorporeal circulation 172
Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine 172
Brief Communication PD1-related Nephrotoxicity: Optimizing Its Clinical Management Through Histopathologic Features 170
Il ruolo dell'infezione da CMV e del suo monitoraggio attivo nella nuova era dei trapianti di rene: risultati di una coorte completa 160
Unusual presentation of secondary syphilis: membranoproliferative glomerulonephritis andmuco-cutaneous lesions 157
Base genetica della microangiopatia trombotica post-trapianto di midollo: l’ultimo tassello del puzzle? [The genetic basis of post-bone marrow transplant thrombotic microangiopathy: is this the last piece of the puzzle?] 151
Letter to the Editor: Kidney Transplantation and Obesity are There Any Differences in Outcomes? 147
Rationale for the evaluation of renal functional reserve in allogeneic stem cell transplantation candidates: a pilot study 145
Diagnosis, treatment, and follow-up of patients with cerebral amyloid angiopathy-related inflammation 144
Purtscher-like retinopathy in a patient with systemic tacrolimus vasculopathy 142
Excellent long-term results in de novo renal transplant recipients treated with proliferation signal inhibitors and reduced calcineurin inhibitors exposure. 135
Excellent long term results in de-novo renal transplant recipients treated with m-TOR inhibitors, basiliximab and reduced calcineurin inhibitors exposure 133
Minimal change disease following vaccination for SARS-CoV-2 129
Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variant 125
A new self-locating peritoneal catheter 123
Transcriptomic analysis after SARS-CoV-2 mRNA vaccination reveals a specific gene signature in low-responder hemodialysis patients 123
THE EVALUATION OF RENAL FUNCTIONAL RESERVE WITH ORAL PROTEIN LOAD OR ULTRASOUND TEST: A REAL-LIFE PERSPECTIVE 119
Biocompatibility of a peritoneal dialysis solution with amino acids: Histological evaluation in the rabbit 119
Kidney vascular damage and cocaine 119
Evaluation of renal functional reserve with oral protein load or new ultrasound test 114
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses 109
Dalla Mailing-List soci SIN (ML-SIN): la sclerosi peritoneale [From the Mailing List SIN: peritoneal sclerosis] 107
Atlas of Peritoneal Histology 106
Videothoracoscopic obliteration of pleuroperitoneal fistula in continuous peritoneal dialysis 105
Dalla Mailing-List soci SIN (ML-SIN). La sclerosi peritoneale: terapia e prevenzione [From the Mailing List SIN: Therapy and prevention of peritoneal sclerosis] 104
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport Syndrome 104
Different Aspects of Peritoneal Damage: Fibrosis and Sclerosis 101
Dialisi peritoneale: metodica a termine a causa della peritonite sclerosante? No, ma ci sono approcci migliori. [Peritoneal dialysis: a time-limited therapy because of encapsulating peritoneal sclerosis? No, but better approaches are available] 99
A collaborative approach to understanding EPS: The European perspective 96
Alport syndrome: a unified classification of genetic disorders of collagen IV α345: a position paper of the Alport Syndrome Classification Working Group 95
Risk factors and action thresholds for the novel coronavirus pandemic. Insights from the Italian Society of Nephrology COVID-19 Survey 93
Primo Case Report di utilizzo dell’Ofatumumab nel trapianto renale AB0 incompatibile [First case report of using Ofatumumab in kidney transplantation AB0 incompatible] 93
Encapsulating peritoneal sclerosis 92
Using Renal Elastography to Predict the Therapeutic Response of Nephrological Patients 90
Early Conversion From Calcineurin Inhibitor- to Everolimus-Based Therapy Following Kidney Transplantation: Results of the Randomized ELEVATE Trial 88
Clinical effects of biocompatible dialysis fluids 88
Health-Related Quality of Life in pre-dialysis patients with chronic kidney disease: the role of Big-Five personality traits and illness denial 80
Immunodeficiency-related high-grade B-cell lymphoma with 11q aberration: Further evidence for a lymphoma entity from a patient with simultaneous papillary renal cell carcinoma following pediatric kidney transplant 78
Sclerosing peritonitis: A nosological entity 77
The social cost of chronic kidney disease in Italy 74
Simple peritoneal sclerosis and sclerosing peritonitis: related or distinct entities? 74
Omental milky spots and peritoneal dialysis - Review and personal experience 71
Peritoneal sclerosis: One or two nosological entities? 71
Morphological aspects of peritoneal sclerosis 70
Mesothelial biocompatibility of peritoneal dialysis solutions 70
The peritoneal dialysis catheter 68
Effetto del naloxone e del naltrexone sulla spesa energetica post-prandiale e sulla risposta del pancreas endocrino ad un pasto misto nell'obesita essenziale. [Effect of naloxone and naltrexone on the postprandial energy expenditure and endocrine pancreas response to a mixed meal in essential obesity] 66
RENAL FUNCTIONAL RESERVE AS A MARKER TO STRATIFY THE RISK OF KIDNEY INJURY IN HEMATOPOIETIC STEM CELL TRANSPLANTATION 66
The rabbit model in evaluating the biocompatibility in peritoneal dialysis 66
No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis 58
Encapsulating Peritoneal Sclerosis - Comment on the 8th GPDP-SIN 2022 Census data 49
Histological and clinical findings in patients with post-transplantation and classical encapsulating peritoneal sclerosis: a European multicenter study 33
null 31
null 2
null 1
Totale 9.078
Categoria #
all - tutte 30.589
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.589


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021417 0 0 0 0 0 53 51 81 61 62 55 54
2021/2022427 38 54 26 46 12 17 14 17 23 40 46 94
2022/20231.049 25 66 123 138 117 234 30 98 120 24 54 20
2023/2024884 25 19 55 36 46 228 282 41 16 17 14 105
2024/20251.836 26 72 146 78 230 135 60 86 169 77 178 579
2025/20262.891 391 654 375 562 872 37 0 0 0 0 0 0
Totale 9.078